About this episode

This episode features a live discussion on recent nephrology trials with experts Alberto Ortiz and Danilo Fliser.

This is “A pinch of salt” live from the 63rd ERA Congress! Recorded straight out of a packed Clyde Plenary Room: six trials, ninety minutes! Hugo Diniz, the new podcast host, brings you rapid-fire expert commentary with two titans of European nephrology, Alberto Ortiz and Danilo Fliser. On the menu — a brand-new CKD drug class (nurandociguat), what patients actually feel on semaglutide (FLOW sub-analysis), two IgA nephropathy therapies going long-term (atrasentan and iptacopan), anticoagulati...

More episodes of A pinch of salt - A podcast by ERA

• #78 B-cell therapy in IgA Nephropathy: worth the hype? with Vlado Perkovic · June 18, 2026 · 36 min
• #77 Generative AI for the busy nephrologist: adapt or perish? with Wisit Cheungpasitporn · June 18, 2026 · 48 min

Explore listener stats, chart rankings, contacts and more on the A pinch of salt - A podcast by ERA podcast page.